Stem Cell Therapy Decreases Covid Deaths
Several clinical studies report increased patient survival following the intravenous infusion of mesenchymal stem cells (MSCs) during the past year. MSCs block the cytokine storm in the lungs and also regenerate cells and tissues damaged by the COVID-19 virus. MSCs are not vaccines and work differently in the treatment of COVID-19.
Click here to read the full White Paper of Stem Cell Therapy Decreases Covid Deaths
Also in White Papers
Stem Cell Activation by Natural Products
Bone marrow stem cell therapies, based on transplant of hematopoietic stem cells (HSCs) have been used for over 50 years in the treatment of blood disorders including leukemia, lymphoma, and auto-immune disorders. Embryonic stem cells (ESCs) were discovered in the late 1990’s by Evans, Kauffman, and Martin. J Thompson developed procedures to isolate and expand ESCs from human embryos. Since ESCs could differentiate into any cell in the body, this expanded application of stem therapy to include broad areas in disease treatment and regenerative medicine.
Comparison of Adipose Stromal Vascular Fraction and Placental Cell Extract
Multipotent mesenchymal stromal/stem cells (MSCs) have the potential to repair and regenerate damaged tissues, making them attractive candidates for cell-based therapies. Expanded and well-characterized MSCs have application in regenerative medicine and have been used in several clinical trials including osteoarthritis and other conditions,
Comparative Analysis of Adult Mesenchymal Stem Cells
Mesenchymal stromal/stem cells (MSCs) have the potential to repair and regenerate damaged tissues, making them attractive candidates for cell-based therapies. Expanded and well-characterized MSCs have application in regenerative medicine and have been used in several clinical trials including treatment for osteoarthritis and other conditions.